12:00 AM
Apr 07, 2014
 |  BioCentury  |  Regulation

Reseeding CDER

CDER urgently recruiting senior managers from industry to replenish top staff

Graying leadership at FDA's Center for Drug Evaluation and Research, combined with a sclerotic hiring process, threatens to create a leadership vacuum at the center, according to Richard Moscicki, deputy director for science operations.

"These positions have been opening up as there has been a graying of the leadership at CDER, with people stepping away to pursue other things or to retire," he told BioCentury. Failing to bring in experienced managers "could bring us to a real crisis in leadership if we don't replenish - and replenish now."

Moscicki, who was VP and head of clinical development at the Genzyme Corp. unit of Sanofi prior to joining FDA in 2013, said CDER cannot meet its needs with internal candidates and is seeking experienced managers from industry.

The list of open positions includes directors and deputy directors of some of the highest profile offices at CDER, officials who represent the face and attitudes of the agency in the eyes of the companies they regulate (see "Help...

Read the full 815 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >